Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CXCL2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CXCL2 encodes macrophage inflammatory protein 2 (MIP-2), a chemokine involved in neuroinflammation and neurodegenerative disease
No AI portrait yet
| Gene Symbol | CXCL2 |
| Full Name | C-X-C Motif Chemokine Ligand 2 |
| Aliases | MIP-2 |
| Chromosome | 4q21.1 |
| Function | is a small chemokine protein that plays critical roles in inflammation, immune cell recruitment, and neuroinflammation. |
| Molecular Weight | 7.8 kDa |
| Amino Acids | 99 aa |
| Pathways | PI3K, MAPK, NF-κB pathway |
| UniProt ID | [P19875](https://www.uniprot.org/uniprot/P19875) |
| Ensembl ID | ENSG00000024836 |
| GeneCards | CXCL2 |
| Human Protein Atlas | CXCL2 |
| N-terminal region | Contains the ELR motif (Glu-Leu-Arg) essential for receptor binding and angiogenic activity |
| CXC motif | Conserved cysteine-cysteine arrangement |
| C-terminal heparin-binding domain | Mediates interaction with extracellular matrix |
| Associated Diseases | Alzheimer, Inflammation |
| Interactions | AGING, Akt, ALZHEIMER, ALZHEIMER'S DISEASE, AND, APOPTOSIS |
| KG Connections | 269 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
CXCL2["CXCL2
Chemokine Ligand 2"]
%% Neuroinflammatory pathway
CXCL2 -->|"activates"| Inflammation["Neuroinflammation
Process"]
Inflammation -->|"leads to"| MS["Multiple Sclerosis
Pathogenesis"]
Inflammation -->|"contributes to"| ALS["ALS
Neurodegeneration"]
%% Cytokine regulation
CXCL2 -->|"inhibits"| IL6["IL-6
Pro-inflammatory Cytokine"]
CXCL2 -->|"inhibits"| IL12B["IL-12B
Th1 Response"]
CXCL2 -->|"inhibits"| IL23A["IL-23A
Th17 Response"]
%% ER stress pathway
CXCL2 -->|"targets"| ATF4["ATF4
ER Stress Response"]
CXCL2 -->|"targets"| XBP1["XBP1
Unfolded Protein Response"]
CXCL2 -->|"targets"| DDIT3["DDIT3/CHOP
ER Stress Apoptosis"]
CXCL2 -->|"targets"| HSPA5["HSPA5/BiP
ER Chaperone"]
%% Blood-brain barrier disruption
CXCL2 -->|"inhibits"| CLDN5["Claudin-5
Tight Junction Protein"]
CXCL2 -->|"inhibits"| OCLN["Occludin
BBB Integrity"]
CLDN5 -->|"maintains"| BBB["Blood-Brain Barrier
Integrity"]
OCLN -->|"maintains"| BBB
%% Aging and fibrosis
CXCL2 -->|"activates"| Aging["Cellular Aging
Process"]
Inflammation -->|"promotes"| Fibrosis["Tissue Fibrosis
Pathology"]
%% Chemokine cross-regulation
CXCL2 -->|"inhibits"| CXCL1["CXCL1
Related Chemokine"]
%% Styling
style CXCL2 fill:#006494
style MS fill:#ef5350
style ALS fill:#ef5350
style Inflammation fill:#ef5350
style Aging fill:#ef5350
style Fibrosis fill:#ef5350
style BBB fill:#1b5e20
style IL6 fill:#4a1a6b
style IL12B fill:#4a1a6b
style IL23A fill:#4a1a6b
style ATF4 fill:#4a1a6b
style XBP1 fill:#4a1a6b
style DDIT3 fill:#4a1a6b
style HSPA5 fill:#4a1a6b
style CLDN5 fill:#1b5e20
style OCLN fill:#1b5e20
style CXCL1 fill:#4a1a6b| Target | Relation | Type | Str |
|---|---|---|---|
| Tumor | activates | disease | 0.75 |
| Fibrosis | inhibits | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Als | treats | disease | 0.65 |
| Carcinoma | interacts_with | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Atherosclerosis | biomarker_for | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Infection | treats | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Ms | biomarker_for | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Tumor | interacts_with | disease | 0.65 |
| Sepsis | inhibits | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| ALS | biomarker_for | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Fibrosis | biomarker_for | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Inflammation | biomarker_for | disease | 0.65 |
| App | therapeutic_target | protein | 0.60 |
| Erk | therapeutic_target | protein | 0.60 |
| INFLAMMATION | inhibits | gene | 0.60 |
| AND | biomarker_for | gene | 0.60 |
| ASTROCYTES | inhibits | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| IL23A | inhibits | gene | 0.60 |
| ALZHEIMER | inhibits | gene | 0.60 |
| ASTROCYTE | inhibits | gene | 0.60 |
| P53 Pathway | expressed_in | pathway | 0.60 |
| RNA | biomarker_for | gene | 0.60 |
| HSPA5 | therapeutic_target | gene | 0.60 |
| CLDN5 | inhibits | gene | 0.60 |
| RNA | therapeutic_target | gene | 0.60 |
| OCLN | inhibits | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| AND | inhibits | gene | 0.60 |
| INFLAMMATION | biomarker_for | gene | 0.60 |
| RNA | biomarker_for | gene | 0.60 |
| AND | biomarker_for | gene | 0.60 |
| NR4A2 | biomarker_for | gene | 0.60 |
| ATF4 | therapeutic_target | gene | 0.60 |
| IL12B | inhibits | gene | 0.60 |
| DDIT3 | therapeutic_target | gene | 0.60 |
| CLDN5 | inhibits | gene | 0.60 |
| IL6 | inhibits | gene | 0.60 |
| IL23A | inhibits | gene | 0.60 |
| OCLN | inhibits | gene | 0.60 |
| CXCL1 | inhibits | gene | 0.60 |
| CXCL10 | associated_with | gene | 0.60 |
| TNF | associated_with | gene | 0.60 |
| BAX | inhibits | gene | 0.60 |
| PANX1 | regulates | gene | 0.60 |
| S100B | regulates | gene | 0.60 |
| RELB | regulates | gene | 0.60 |
| P2RY1 | regulates | gene | 0.60 |
| CASP3 | regulates | gene | 0.60 |
| SOCS3 | regulates | gene | 0.60 |
| TRPA1 | regulates | gene | 0.60 |
| ATF4 | activates | gene | 0.60 |
| IL1A | associated_with | gene | 0.60 |
| XBP1 | activates | gene | 0.60 |
| HSPA5 | activates | gene | 0.60 |
| JAK1 | biomarker_for | gene | 0.60 |
| NLRP3 | activates | gene | 0.60 |
| NLRP3 | regulates | gene | 0.60 |
| TNF | regulates | gene | 0.60 |
| CXCL10 | regulates | gene | 0.60 |
| CD14 | activates | gene | 0.60 |
| JUN | activates | gene | 0.60 |
| CLDN5 | activates | entity | 0.60 |
| CXCL1 | activates | entity | 0.60 |
| CYTOKINES | inhibits | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| TNFRSF19 | biomarker_for | gene | 0.60 |
| CYTOKINES | regulates | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| IL-6 | regulates | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| AMYLOID | regulates | gene | 0.60 |
| TNF-Α | regulates | gene | 0.60 |
| BRAIN INFLAMMATION | associated_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| CCR9 | biomarker_for | gene | 0.60 |
| TNF | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| SASP Secretome-based Molecular Distinction via CXCL1/CXCL2/M | 0.720 | neurodegeneration | How can senescent microglia be molecular |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CXCL2 in their description or question text
No additional research found